| 000 | 01826 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517093648.0 | ||
| 264 | 0 | _c20170217 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1742-7843 | ||
| 024 | 7 |
_a10.1111/bcpt.12615 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIavecchia, Luján | |
| 245 | 0 | 0 |
_aImpact of Implementing a Protocol on the Perioperative Management in Patients Treated with Antithrombotics Admitted for Hip Fracture Surgery: an Observational Study. _h[electronic resource] |
| 260 |
_bBasic & clinical pharmacology & toxicology _cNov 2016 |
||
| 300 |
_a476-484 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aHip Fractures _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPerioperative Care |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 |
_aThromboembolism _xprevention & control |
| 700 | 1 | _aSafiya, Ahmad | |
| 700 | 1 | _aSalat, David | |
| 700 | 1 | _aSabaté, Mònica | |
| 700 | 1 | _aBosch, Montse | |
| 700 | 1 | _aBiarnés, Alfons | |
| 700 | 1 | _aCamps, Angels | |
| 700 | 1 | _aCastellà, Dolors | |
| 700 | 1 | _aLalueza, Pilar | |
| 700 | 1 | _aPons, Verònica | |
| 700 | 1 | _aTeixidor, Jordi | |
| 700 | 1 | _aVillar, Maria M | |
| 700 | 1 | _aAgustí, Antònia | |
| 773 | 0 |
_tBasic & clinical pharmacology & toxicology _gvol. 119 _gno. 5 _gp. 476-484 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcpt.12615 _zAvailable from publisher's website |
| 999 |
_c25993392 _d25993392 |
||